In Brief: Schneider v. Scimed
This article was originally published in The Gray Sheet
Executive Summary
Schneider v. Scimed: U.S. Court of Appeals for the Federal Circuit upholds March 1994 district court ruling that Scimed must pay Schneider $64 mil. in damages for infringing an angioplasty catheter patent held by the Pfizer subsidiary, Scimed parent Boston Scientific announces. The lower court ruled that Scimed's Express and Rally rapid exchange catheters infringed the "Bonzel" patent, which covers Schneider's line of rapid exchange dilatation catheters ("The Gray Sheet" March 14, 1994, p. 1). Boston Scientific says that the appeals court ruling "will not have any material affect" on its financial position...